Quick Answer (for busy buyers)
Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.
- For AHA/BHA skincare in the UK, we control sting and irritation by optimizing pH levels, typically between 3.5 and 4.0, using buffers like sodium citrate.
- We incorporate soothing agents such as panthenol or bisabolol to counteract potential sensitivity, and conduct patch testing during sampling. pH stability is ensured through accelerated stability testing over 3 months, checking for shifts under various temperature conditions.
- MOQ starts at 3000 units per SKU to justify production costs, with sampling timelines of 2-3 weeks for initial prototypes.
- We handle compliance by preparing UK-specific documents, including CPSR and safety assessments, and use compatible packaging like airless pumps to prevent oxidation.
- Lead time from approval to bulk production is 8-10 weeks, supported by QA checks for microbial limits and ingredient dispersion.
- We assist with all necessary testing and documentation for regulatory alignment, but final approval depends on your brand’s due diligence.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.